Creatinine Test Market Research Report - Global Forecast till 2023

Creatinine Test Market Research Report - Global Forecast till 2023

ID: MRFR/HC/3449-CRR | | Region: Global | 110 pages | Cooked Research Reports

Global  Creatinine  Test  Market  Research  Report  By  Test  Type  (Blood  Test,  Urine  Test  and  Creatinine  Clearance  Test),  By  Product  Type  (Consumables  and  Instruments),  By  Application  (Urinary  Tract  Obstruction,  Renal  Failure,  Kidney  Cancer,  Glomerulonephritis  and  Others),  By  End  User  (Hospital  &  Clinics,  Diagnostic  Center,  Research  Institutes  and  Others),  By  Region  –  Forecast  to  2023   


Market Description


The global creatinine test market is anticipated to reach USD 604.5 million by 2023, as per a new report by Market Research Future (MRFR). It is expected to exhibit a phenomenal CAGR during the assessment period (2017-2023). The growth is supplemented by government initiatives and campaigns to create awareness among users to minimize the incidence of chronic kidney diseases. In addition, launch of diagnostic tests annually by current and new manufacturers is anticipated to spur market growth over the forecast period.


Creatinine tests are an array of tests used in checking on creatinine levels in kidneys. Creatinine is a waste product filtered through the kidneys and excreted via urine. Excess of creatinine in the blood can lead to kidney failure. Tests such as creatinine clearance and others to discern the glomerular filtration rate (GFR) are expected to diagnose chronic kidney disease at an early stage. Automation of laboratory tests and rise in research and development to expedite testing rates are expected to augur the creatinine test market over the forecast period.


Unmet needs for efficient creatinine level diagnostic tests coupled with sedentary lifestyles globally are factors expected to drive market growth. Technological advances in these tests can detect improper functioning of the kidneys. The application of creatinine tests in emergency wards, outpatient clinics, and hospitals can provide new opportunities for the market.


Report Overview


This report allows the user to gain a deeper understanding of the ongoing events and trends in the global market for creatinine tests. By correlating the historical data with key market dynamics, analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global creatinine test market segmented by test type, product type, application, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.


Segment Overview


By test type, the creatinine test market has been segmented into urine test, creatinine clearance test, and blood test. By product type, the market is segmented into consumables and instruments. Based on application, the market has been segmented into glomerulonephritis, kidney cancer, renal failure, urinary tract obstruction, and others. End-users covered are research institutes, diagnostic centers, hospitals & clinics, and others.  


The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific, and the Middle East and Africa, with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “creatinine test” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.


Players Covered


Quest Diagnostics, Thermo Fisher Scientific, Inc., Abbott, F. Hoffmann-La Roche AG, ARKRAY, Inc., ACON Laboratories, Inc., Abcam plc, URIT Medical, The Danaher Corporation, Siemens AG, Nova Biomedical, OPTI Medical Systems, and others are prominent players in the creatinine test market.


The report offers comprehensive profiles on these market players and assesses their current standing in the market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.


Research Methodology


Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report consists of news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.


Analysis Period



  • Base Year - 2016

  • Projection Period - From 2017 to 2023

  • Market Denomination - USD Million

  • Conversion Rate - Considered as per the respective financial years


For the scope of the research, the report offers a comprehensive analysis of the global creatinine test market


Test Type



  • Blood Test

    • Blood Urea Nitrogen Test

    • Serum Creatinine Test

    • Estimated Glomerular Filtration (eGFR) Test



  • Urine Test

    • A:C Test

    • P:C Test



  • Creatinine Clearance Test


By Product Type



  • Consumables

    • Cartridge

    • Urine Test Strips

    • Others



  • Instruments

    • Clinical Analyzers

      • Benchtop Clinical Analyzer

        • Automated

        • Semi-automated



      • Handheld Clinical Analyzer



    • Others




Application



  • Urinary Tract Obstruction

  • Glomerulonephritis

  • Kidney Cancer

  • Renal Failure

  • Others


End User



  • Research Institutes

  • Diagnostic Centers

  • Hospitals & Clinics

  • Others


 By Region



  • Americas; North America and South America,

  • Europe; Western and Eastern Europe

  • Asia Pacific (APAC); China, Japan, India, Australia, Republic of Korea, and Rest of Asia Pacific

  • Middle East & Africa; The Middle East and Africa


Intended Audience



  • Diagnostic Centers

  • Research and Development (R&D) Companies

  • Government Research Institutes

  • Academic Institutes and Universities

Global Creatinine Test Market: Report Summary


The global creatinine test market is anticipated to reach a valuation of USD 604.55 million by 2023, expanding at a 5.8% CAGR during the assessment period (2018-2023). Alarming cases of kidney disorders, namely chronic kidney disease (CKD) among patients is expected to be the primary driver of the market. In addition, government initiatives by various nations to create awareness among patients can propel market demand in the coming years.


Creatinine tests are an array of tests used to discern creatinine levels in the blood. Creatinine is a waste product created during the breakdown of creatine, an organic acid found in vertebrates. Development of various tests such as blood urea nitrogen (BUN) test, estimated glomerular filtration rate (eGFR) test, and others can provide accurate results and assist in preventive healthcare. The rise in the geriatric populace and increasing cases of diabetics can purportedly drive the demand for creatinine tests over the forecast period.


The creatinine test market has been segmented by test type, product type, application, end-user, and region. By type, the market is segmented into blood test, creatinine clearance test, and urine test. The blood test segment is expected to generate market revenue owing to high preference of blood tests to measure creatinine levels. It was worth USD 211.83 million in 2016 and purportedly expand at a 5.32% CAGR during the forecast period. The urine test segment can grow robustly over the forecast period owing to advances in urine test strips to determine a rapid and accurate diagnosis of kidney disorders.


By product type, the market is segmented into consumables and instruments. The consumables segment is likely to register a remarkable growth rate during the forecast period owing to urine test strips and cartridges being used for rapid diagnosis of creatinine in the urine. The instruments segment is projected to grow at a brisk pace and exhibit a 6% CAGR during the forecast period.


On the basis of application, the market has been segmented into kidney cancer, renal failure, glomerulonephritis, urinary tract obstruction, and others. The urinary tract obstruction segment is expected to showcase a 5.10% CAGR over the forecast period owing to serum creatinine tests used to determine blockage of the urinary tract.


Major market end-users include research institutes, diagnostic centers, hospitals and clinics, and others. The diagnostic centers segment is projected to register a 6.34% CAGR during the forecast period owing to high demand for early diagnosis of CKD.


Regional Analysis


On the basis of regions, the global creatinine test market has been segmented into Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).


The Americas market accounted for a large market share owing to presence of various leaders of the healthcare industry, expanded healthcare budget, reimbursement policies, and prevalence of various kidney diseases. According to a 2017 report by the National Center for Chronic Disease and Prevention, nearly 30 million citizens in the U.S. were dealing with some form of kidney disorder. Inclination towards quality healthcare is expected to bode well for the market over the forecast period.


The Europe market is expected to exhibit a 6.12% CAGR from 2017 to 2023. Countries such as the U.K., France, and Germany are projected to contribute to market demand owing to change in healthcare policies.


The APAC market is deemed to grow at a rapid pace during the forecast period owing to a large patient pool, improving healthcare infrastructure, and changing healthcare models of hospitals. It is expected to exhibit a 6.33% CAGR from 2017 to 2023 owing to helpful government initiatives to create awareness and subsidies offered to hospitals for implementation of rapid diagnostic tests.


Competitive Analysis


Siemens AG, Abcam plc, ACON Laboratories, Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc., Quest Diagnostics, URIT Medical, The Danaher Corporation, Abbott Diagnostics Inc., Nova Biomedical, OPTI Medical Systems, ARKRAY, Inc., and others are some of the noteworthy players in the creatinine test market. Acquisitions and new product launches are strategies employed by players to gain a larger share in the market. Development of new standards by regulatory agencies to ease the approval process of new product launches is expected to open up new growth opportunities for the market. For instance, BUN and total carbon dioxide (TCO2) point-of-care tests by Siemens Healthcare were approved in 2018 by the U.S. Food and Drug Administration (FDA) to assist in the diagnosis of renal diseases.


 

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

3.1 Definition 23

3.2 Scope of the Study 23

3.3 Assumptions & Limitations 23

3.3.1 Assumptions 23

3.3.2 Limitations 23

3.4 Market Structure 24

4.1 Research Process 26

4.2 Primary Research 27

4.3 Secondary Research 28

4.4 Market Size Estimation 29

4.5 Forecast Model 29

5.1 Introduction 31

5.2 Drivers 32

5.2.1 Prevalence of chronic kidney disease 32

5.2.2 Technological advancements in the kidney function testing 32

5.2.3 Initiatives taken by government to control chronic kidney diseases 33

5.3 Restraints 33

5.3.1 False estimates of creatinine testing 33

5.4 Opportunities 33

5.4.1 Rising approval from FDA 33

5.5 Macroeconomic Indicators 34

6.1 Supply Chain Analysis 36

6.1.1 R&D 36

6.1.2 Parts Manufacturing 36

6.1.3 Distribution 36

6.1.4 Marketing & Sales 36

6.1.5 Post-Sales Monitoring 36

6.2 Demand & Supply: Gap Analysis 37

6.3 Pricing Analysis 37

6.4 Investment Opportunities 37

6.5 Porter’s Five Forces Model 38

6.5.1 Bargaining Power of Suppliers 38

6.5.2 Bargaining Power of Buyers 38

6.5.3 Threat of New Entrants 39

6.5.4 Threat of Substitutes 39

6.5.5 Intensity of Rivalry 39

7.1 Overview 41

7.1.1 Blood Test 41

7.1.2 Urine Test 41

7.1.3 Creatinine Clearance Test 41

8.1 Overview 46

8.1.1 Consumables 46

8.1.2 Instruments 46

9.1 Overview 51

9.1.1 Urinary Tract Obstruction 51

9.1.2 Renal Failure 51

9.1.3 Kidney Cancer 51

9.1.4 Glomerulonephritis 51

10.1 Overview 55

10.1.1 Hospital & Clinics 55

10.1.2 Diagnostic Centre 55

10.1.3 Research Institutes 55

11.1 Introduction 59

11.2 Americas 61

11.2.1 North America 65

11.2.2 South America 74

11.3 Europe 78

11.3.1 Western Europe 82

11.3.2 Eastern Europe 103

11.4 Asia Pacific 107

11.4.1 Japan 111

11.4.2 China 114

11.4.3 India 117

11.4.4 Australia 120

11.4.5 Republic of Korea 123

11.4.6 Rest of Asia Pacific 126

11.5 The Middle East and Africa 130

11.5.1 Middle East 134

11.5.2 Africa 137

12.1 Company Market Share Analysis 141

12.1.1 Introduction 141

12.2 Competitive Landscape 142

12.2.1 Introduction 142

12.3 Key Developments 143

13.1 Siemens AG 145

13.1.1 Company Overview 145

13.1.2 Financial Overview 145

13.1.3 Products Offerings 146

13.1.4 Key Developments 146

13.1.5 SWOT Analysis 146

13.1.6 Key Strategy 147

13.2 Abbott 148

13.2.1 Company Overview 148

13.2.2 Financial Overview 148

13.2.3 Products Offerings 148

13.2.4 Key Developments 149

13.2.5 SWOT Analysis 149

13.2.6 Key Strategy 149

13.3 Thermo Fisher Scientific Inc 150

13.3.1 Company Overview 150

13.3.2 Financial Overview 150

13.3.3 Products Offerings 151

13.3.4 Key Developments 151

13.3.5 SWOT Analysis 151

13.3.6 Key Strategy 151

13.4 Abcam plc 152

13.4.1 Company Overview 152

13.4.2 Financial Overview 152

13.4.3 Products Offerings 152

13.4.4 Key Developments 153

13.4.5 SWOT Analysis 153

13.4.6 Key Strategy 153

13.5 F. Hoffmann-La Roche AG 154

13.5.1 Company Overview 154

13.5.2 Financial Overview 154

13.5.3 Products Offerings 155

13.5.4 Key Developments 155

13.5.5 SWOT Analysis 155

13.5.6 Key Strategy 155

13.6 Nova Biomedical 156

13.6.1 Company Overview 156

13.6.2 Products Offerings 156

13.6.3 Key Developments 156

13.6.4 SWOT Analysis 157

13.6.5 Key Strategy 157


13.7 ACON Laboratories, Inc. 158

13.7.1 Company Overview 158

13.7.2 Products Offerings 158

13.7.3 Key Developments 158

13.7.4 SWOT Analysis 158

13.7.5 Key Strategy 158

13.8 OPTI Medical Systems 159

13.8.1 Company Overview 159

13.8.2 Products Offerings 159

13.8.3 Key Developments 159

13.8.4 SWOT Analysis 159

13.8.5 Key Strategy 159

13.9 URIT Medical 160

13.9.1 Company Overview 160

13.9.2 Products Offerings 160

13.9.3 Key Developments 160

13.9.4 SWOT Analysis 160

13.9.5 Key Strategy 160

13.10 Quest Diagnostics 161

13.10.1 Company Overview 161

13.10.2 Financial Overview 161

13.10.3 Products Offerings 162

13.10.4 Key Developments 162

13.10.5 SWOT Analysis 162

13.10.6 Key Strategy 162

13.11 ARKRAY, Inc. 163

13.11.1 Company Overview 163

13.11.2 Products Offerings 163

13.11.3 Key Developments 163

13.11.4 SWOT Analysis 163

13.11.5 Key Strategy 163

13.12 Danaher 164

13.12.1 Company Overview 164

13.12.2 Products Offerings 165

13.12.3 Key Developments 165

13.12.4 SWOT Analysis 165

13.12.5 Key Strategy 165

14.1 Key Findings 167

14.1.1 CEO’s Viewpoint 167

14.1.2 Unmet Needs 167

14.1.3 Key Companies to Watch 167

14.1.4 Prediction 167

15.1 Discussion Blue Print 169

15.2 References 170


TABLE 1 MARKET SYNOPSIS 21

TABLE 2 PRIMARY INTERVIEWS 27

TABLE 3 GLOBAL CREATININE TEST MARKET FOR BLOOD TEST, BY REGION 2014-2023 (USD MILLION) 42

TABLE 4 GLOBAL CREATININE TEST MARKET FOR SERUM CREATININE TEST, BY REGION 2014-2023 (USD MILLION) 42

TABLE 5 GLOBAL CREATININE TEST MARKET FOR EGFR TEST, BY REGION 2014-2023 (USD MILLION) 43

TABLE 6 GLOBAL CREATININE TEST MARKET FOR BLOOD UREA NITROGEN TEST, BY REGION 2014-2023 (USD MILLION) 43

TABLE 7 GLOBAL CREATININE TEST MARKET FOR URINE TEST, BY REGION 2014-2023 (USD MILLION) 43

TABLE 8 GLOBAL CREATININE TEST MARKET FOR A: C TEST, BY REGION 2014-2023 (USD MILLION) 44

TABLE 9 GLOBAL CREATININE TEST MARKET FOR P: C TEST, BY REGION 2014-2023 (USD MILLION) 44

TABLE 10 GLOBAL CREATININE TEST MARKET FOR CREATININE CLEARANCE TEST, BY REGION 2014-2023 (USD MILLION) 44

TABLE 11 GLOBAL CREATININE TEST MARKET FOR CONSUMABLE, BY REGION 2014-2023 (USD MILLION) 47

TABLE 12 GLOBAL CREATININE TEST MARKET FOR URINE TEST STRIPS, BY REGION 2014-2023 (USD MILLION) 47

TABLE 13 GLOBAL CREATININE TEST MARKET FOR CARTRIDGE, BY REGION 2014-2023 (USD MILLION) 47

TABLE 14 GLOBAL CREATININE TEST MARKET FOR INSTRUMENTS, BY REGION 2014-2023 (USD MILLION) 48

TABLE 15 GLOBAL CREATININE TEST MARKET FOR CLINICAL ANALYZER, BY REGION 2014-2023 (USD MILLION) 48

TABLE 16 GLOBAL CREATININE TEST MARKET FOR BENCH TOP CLINICAL ANALYZER, BY REGION 2014-2023 (USD MILLION) 48

TABLE 17 GLOBAL CREATININE TEST MARKET FOR AUTOMATED, BY REGION 2014-2023 (USD MILLION) 49

TABLE 18 GLOBAL CREATININE TEST MARKET FOR SEMI AUTOMATED, BY REGION 2014-2023 (USD MILLION) 49

TABLE 19 GLOBAL CREATININE TEST MARKET FOR HANDHELD CLINICAL ANALYZER, BY REGION 2014-2023 (USD MILLION) 49

TABLE 20 GLOBAL CREATININE TEST MARKET FOR URINARY TRACT OBSTRUCTION, BY REGION 2014-2023 (USD MILLION) 52

TABLE 21 GLOBAL CREATININE TEST MARKET FOR RENAL FAILURE, BY REGION 2014-2023 (USD MILLION) 52

TABLE 22 GLOBAL CREATININE TEST MARKET FOR KIDNEY CANCER, BY REGION 2014-2023 (USD MILLION) 53

TABLE 23 GLOBAL CREATININE TEST MARKET FOR GLOMERULONEPHRITIS, BY REGION 2014-2023 (USD MILLION) 53

TABLE 24 GLOBAL CREATININE TEST MARKET FOR HOSPITAL & CLINICS, BY REGION 2014-2023 (USD MILLION) 56

TABLE 25 GLOBAL CREATININE TEST MARKET FOR DIAGNOSTIC CENTER, BY REGION 2014-2023 (USD MILLION) 56

TABLE 26 GLOBAL CREATININE TEST MARKET FOR RESEARCH INSTITUTES, BY REGION 2014-2023 (USD MILLION) 57

TABLE 27 GLOBAL CREATININE TEST MARKET, BY REGION, 2014-2023 (USD MILLION) 59

TABLE 28 AMERICAS: CREATININE TEST MARKET, BY REGION, 2014-2023 (USD MILLION) 61

TABLE 29 AMERICAS: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 62

TABLE 30 AMERICAS CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 62

TABLE 31 AMERICAS CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 62

TABLE 32 AMERICAS: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 62

TABLE 33 AMERICAS: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 63

TABLE 34 AMERICAS: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 63

TABLE 35 AMERICAS: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 63

TABLE 36 AMERICAS: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 63

TABLE 37 AMERICAS: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 64

TABLE 38 AMERICAS: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 64

TABLE 39 NORTH AMERICA: CREATININE TEST MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 65

TABLE 40 NORTH AMERICA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 65

TABLE 41 NORTH AMERICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 65

TABLE 42 NORTH AMERICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 66

TABLE 43 NORTH AMERICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 66

TABLE 44 NORTH AMERICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 66

TABLE 45 NORTH AMERICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 66

TABLE 46 NORTH AMERICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 67

TABLE 47 NORTH AMERICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 67

TABLE 48 NORTH AMERICA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 67

TABLE 49 NORTH AMERICA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 68

TABLE 50 U.S.: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 68

TABLE 51 U.S. CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 68

TABLE 52 U.S. CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 69

TABLE 53 U.S.: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 69

TABLE 54 U.S.: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 69

TABLE 55 U.S.: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 69

TABLE 56 U.S.: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 70

TABLE 57 U.S.: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 70

TABLE 58 U.S.: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 70

TABLE 59 U.S.: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 71

TABLE 60 CANADA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 71

TABLE 61 CANADA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 71

TABLE 62 CANADA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 72

TABLE 63 CANADA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 72

TABLE 64 CANADA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 72

TABLE 65 CANADA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 72

TABLE 66 CANADA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 73

TABLE 67 CANADA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 73

TABLE 68 CANADA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 73

TABLE 69 CANADA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 74

TABLE 70 SOUTH AMERICA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 74

TABLE 71 SOUTH AMERICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 74

TABLE 72 SOUTH AMERICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 75

TABLE 73 SOUTH AMERICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 75

TABLE 74 SOUTH AMERICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 75

TABLE 75 SOUTH AMERICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 75

TABLE 76 SOUTH AMERICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 76

TABLE 77 SOUTH AMERICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 76

TABLE 78 SOUTH AMERICA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 76

TABLE 79 SOUTH AMERICA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 77

TABLE 80 EUROPE: CREATININE TEST MARKET, BY REGION, 2014-2023 (USD MILLION) 78

TABLE 81 EUROPE: CREATININE TEST MARKET, BY REGION, 2014-2023 (USD MILLION) 78

TABLE 82 EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 79

TABLE 83 EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 79

TABLE 84 EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 79

TABLE 85 EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 79

TABLE 86 EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 80

TABLE 87 EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 80

TABLE 88 EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 80

TABLE 89 EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 80

TABLE 90 EUROPE: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 81

TABLE 91 EUROPE: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 81

TABLE 92 WESTERN EUROPE: CREATININE TEST MARKET, BY REGION, 2014-2023 (USD MILLION) 82

TABLE 93 WESTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 82

TABLE 94 WESTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 82

TABLE 95 WESTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 83

TABLE 96 WESTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 83

TABLE 97 WESTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 83

TABLE 98 WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 83

TABLE 99 WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 84

TABLE 100 WESTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 84

TABLE 101 WESTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 84

TABLE 102 WESTERN EUROPE: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 85

TABLE 103 GERMANY: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 85

TABLE 104 GERMANY CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 85

TABLE 105 GERMANY CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 86

TABLE 106 GERMANY: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 86

TABLE 107 GERMANY: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 86

TABLE 108 GERMANY: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 86

TABLE 109 GERMANY: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 87

TABLE 110 GERMANY: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 87

TABLE 111 GERMANY: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 87

TABLE 112 GERMANY: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 88

TABLE 113 FRANCE: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 88

TABLE 114 FRANCE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 88

TABLE 115 FRANCE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 89

TABLE 116 FRANCE: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 89

TABLE 117 FRANCE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 89

TABLE 118 FRANCE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 89

TABLE 119 FRANCE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 90

TABLE 120 FRANCE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 90

TABLE 121 FRANCE: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 90

TABLE 122 FRANCE: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 91

TABLE 123 U.K: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 91

TABLE 124 U.K CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 91

TABLE 125 U.K CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 92

TABLE 126 U.K: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 92

TABLE 127 U.K: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 92

TABLE 128 U.K: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 92

TABLE 129 U.K: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 93

TABLE 130 U.K: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 93

TABLE 131 U.K: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 93

TABLE 132 U.K: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 94

TABLE 133 ITALY: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 94

TABLE 134 ITALY CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 94

TABLE 135 ITALY CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 95

TABLE 136 ITALY: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 95

TABLE 137 ITALY: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 95

TABLE 138 ITALY: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 95

TABLE 139 ITALY: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 96

TABLE 140 ITALY: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 96

TABLE 141 ITALY: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 96

TABLE 142 ITALY: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 97

TABLE 143 SPAIN: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 97

TABLE 144 SPAIN CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 97

TABLE 145 SPAIN CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 98

TABLE 146 SPAIN: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 98

TABLE 147 SPAIN: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 98

TABLE 148 SPAIN: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 98

TABLE 149 SPAIN: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 99

TABLE 150 SPAIN: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 99

TABLE 151 SPAIN: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 99

TABLE 152 SPAIN: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 100

TABLE 153 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 100

TABLE 154 REST OF WESTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 100

TABLE 155 REST OF WESTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 101

TABLE 156 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 101

TABLE 157 REST OF WESTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 101

TABLE 158 REST OF WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 101

TABLE 159 REST OF WESTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE,

2014-2023 (USD MILLION) 102

TABLE 160 REST OF WESTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE,

2014-2023 (USD MILLION) 102

TABLE 161 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 102

TABLE 162 REST OF WESTERN EUROPE: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 103

TABLE 163 EASTERN EUROPE: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 103

TABLE 164 EASTERN EUROPE CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 103

TABLE 165 EASTERN EUROPE CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 104

TABLE 166 EASTERN EUROPE: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 104

TABLE 167 EASTERN EUROPE: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 104

TABLE 168 EASTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 104

TABLE 169 EASTERN EUROPE: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 105

TABLE 170 EASTERN EUROPE: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 105

TABLE 171 EASTERN EUROPE: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 105

TABLE 172 EASTERN EUROPE: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 106

TABLE 173 ASIA PACIFIC: CREATININE TEST MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 107

TABLE 174 ASIA PACIFIC: CREATININE TEST MARKET, BY COUNTRY, 2014-2023 (USD MILLION) 108

TABLE 175 ASIA PACIFIC: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 108

TABLE 176 ASIA PACIFIC CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 108

TABLE 177 ASIA PACIFIC CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 109

TABLE 178 ASIA PACIFIC: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 109

TABLE 179 ASIA PACIFIC: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 109

TABLE 180 ASIA PACIFIC: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 109

TABLE 181 ASIA PACIFIC: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 110

TABLE 182 ASIA PACIFIC: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 110

TABLE 183 ASIA PACIFIC: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 110

TABLE 184 ASIA PACIFIC: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 111

TABLE 185 JAPAN: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 111

TABLE 186 JAPAN CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 111

TABLE 187 JAPAN CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 112

TABLE 188 JAPAN: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 112

TABLE 189 JAPAN: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 112

TABLE 190 JAPAN: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 112

TABLE 191 JAPAN: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 113

TABLE 192 JAPAN: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 113

TABLE 193 JAPAN: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 113

TABLE 194 JAPAN: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 114

TABLE 195 CHINA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 114

TABLE 196 CHINA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 114

TABLE 197 CHINA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 115

TABLE 198 CHINA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 115

TABLE 199 CHINA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 115

TABLE 200 CHINA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 115

TABLE 201 CHINA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 116

TABLE 202 CHINA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 116

TABLE 203 CHINA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 116

TABLE 204 CHINA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 117

TABLE 205 INDIA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 117

TABLE 206 INDIA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 117

TABLE 207 INDIA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 118

TABLE 208 INDIA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 118

TABLE 209 INDIA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 118

TABLE 210 INDIA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 118

TABLE 211 INDIA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 119

TABLE 212 INDIA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 119

TABLE 213 INDIA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 119

TABLE 214 INDIA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 120

TABLE 215 AUSTRALIA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 120

TABLE 216 AUSTRALIA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 120

TABLE 217 AUSTRALIA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 121

TABLE 218 AUSTRALIA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 121

TABLE 219 AUSTRALIA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 121

TABLE 220 AUSTRALIA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 121

TABLE 221 AUSTRALIA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 122

TABLE 222 AUSTRALIA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 122

TABLE 223 AUSTRALIA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 122

TABLE 224 AUSTRALIA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 123

TABLE 225 REPUBLIC OF KOREA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 123

TABLE 226 REPUBLIC OF KOREA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 123

TABLE 227 REPUBLIC OF KOREA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 124

TABLE 228 REPUBLIC OF KOREA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 124

TABLE 229 REPUBLIC OF KOREA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 124

TABLE 230 REPUBLIC OF KOREA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 124

TABLE 231 REPUBLIC OF KOREA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE,

2014-2023 (USD MILLION) 125

TABLE 232 REPUBLIC OF KOREA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 125

TABLE 233 REPUBLIC OF KOREA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 125

TABLE 234 REPUBLIC OF KOREA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 126

TABLE 235 REST OF ASIA PACIFIC: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 126

TABLE 236 REST OF ASIA PACIFIC CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 126

TABLE 237 REST OF ASIA PACIFIC CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 127

TABLE 238 REST OF ASIA PACIFIC: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 127

TABLE 239 REST OF ASIA PACIFIC: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 127

TABLE 240 REST OF ASIA PACIFIC: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 127

TABLE 241 REST OF ASIA PACIFIC: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE,

2014-2023 (USD MILLION) 128

TABLE 242 REST OF ASIA PACIFIC: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE,

2014-2023 (USD MILLION) 128

TABLE 243 REST OF ASIA PACIFIC: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 128

TABLE 244 REST OF ASIA PACIFIC: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 129

TABLE 245 AMERICAS: CREATININE TEST MARKET, BY REGION, 2014-2023 (USD MILLION) 130

TABLE 246 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET, BY REGION, 2014-2023 (USD MILLION) 130

TABLE 247 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 131

TABLE 248 THE MIDDLE EAST AND AFRICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 131

TABLE 249 THE MIDDLE EAST AND AFRICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 131

TABLE 250 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 131

TABLE 251 THE MIDDLE EAST AND AFRICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 132

TABLE 252 THE MIDDLE EAST AND AFRICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 132

TABLE 253 THE MIDDLE EAST AND AFRICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE,

2014-2023 (USD MILLION) 132

TABLE 254 THE MIDDLE EAST AND AFRICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE,

2014-2023 (USD MILLION) 132

TABLE 255 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 133

TABLE 256 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 133

TABLE 257 MIDDLE EAST: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 134

TABLE 258 MIDDLE EAST CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 134

TABLE 259 MIDDLE EAST CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 134

TABLE 260 MIDDLE EAST: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 135

TABLE 261 MIDDLE EAST: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 135

TABLE 262 MIDDLE EAST: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 135

TABLE 263 MIDDLE EAST: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 135

TABLE 264 MIDDLE EAST: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 136

TABLE 265 MIDDLE EAST: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 136

TABLE 266 MIDDLE EAST: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 136

TABLE 267 AFRICA: CREATININE TEST MARKET BY TEST TYPE, 2014-2023 (USD MILLION) 137

TABLE 268 AFRICA CREATININE TEST MARKET FOR BLOOD TEST BY TYPE, 2014-2023 (USD MILLION) 137

TABLE 269 AFRICA CREATININE TEST MARKET FOR URINE TEST BY TYPE, 2014-2023 (USD MILLION) 137

TABLE 270 AFRICA: CREATININE TEST MARKET BY PRODUCT TYPE, 2014-2023 (USD MILLION) 138

TABLE 271 AFRICA: CREATININE TEST CONSUMABLES MARKET, BY TYPE, 2014-2023 (USD MILLION) 138

TABLE 272 AFRICA: CREATININE TEST INSTRUMENTS MARKET, BY TYPE, 2014-2023 (USD MILLION) 138

TABLE 273 AFRICA: CREATININE TEST INSTRUMENTS MARKET FOR CLINICAL ANALYSER, BY TYPE, 2014-2023 (USD MILLION) 138

TABLE 274 AFRICA: CREATININE TEST CLINICAL ANALYZER MARKET FOR BENCH TOP, BY TYPE, 2014-2023 (USD MILLION) 139

TABLE 275 AFRICA: CREATININE TEST MARKET BY APPLICATION, 2014-2023 (USD MILLION) 139

TABLE 276 AFRICA: CREATININE TEST MARKET BY END USER, 2014-2023 (USD MILLION) 139

TABLE 277 GLOBAL CREATININE TEST MARKET: KEY DEVELOPMENT 143

FIGURE 1 GLOBAL CREATININE TEST MARKET: MARKET STRUCTURE 24

FIGURE 2 RESEARCH PROCESS OF MRFR 26

FIGURE 3 TOP DOWN & BOTTOM UP APPROACH 29

FIGURE 4 MARKET DYNAMICS ANALYSIS OF GLOBAL CREATININE TEST MARKET 31

FIGURE 5 SUPPLY CHAIN: CREATININE TEST MARKET 36

FIGURE 6 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL CREATININE TEST MARKET 38

FIGURE 7 GLOBAL CREATININE TEST MARKET, BY TEST TYPE, 2016 (%) 41

FIGURE 8 GLOBAL CREATININE TEST MARKET, BY TEST TYPE, 2016 & 2023 (USD MILLION) 42

FIGURE 9 GLOBAL CREATININE TEST MARKET, BY PRODUCT TYPE, 2016 (%) 46

FIGURE 10 GLOBAL CREATININE TEST MARKET, BY PRODUCT TYPE, 2016 & 2023 (USD MILLION) 46

FIGURE 11 GLOBAL CREATININE TEST MARKET, BY APPLICATION, 2016 (%) 51

FIGURE 12 GLOBAL CREATININE TEST MARKET, BY APPLICATION, 2016 & 2023 (USD MILLION) 52

FIGURE 13 GLOBAL CREATININE TEST MARKET, BY END USER, 2016 (%) 55

FIGURE 14 GLOBAL CREATININE TEST MARKET, BY END USER, 2016 & 2023 (USD MILLION) 56

FIGURE 15 GLOBAL CREATININE TEST MARKET, BY REGION, 2016 & 2023 (USD MILLION) 59

FIGURE 16 GLOBAL CREATININE TEST MARKET, BY REGION, 2016 (%) 60

FIGURE 17 AMERICAS: CREATININE TEST MARKET SHARE, BY REGION, 2016 (%) 61

FIGURE 18 EUROPE: CREATININE TEST MARKET SHARE, BY REGION, 2016 (%) 78

FIGURE 19 ASIA PACIFIC: CREATININE TEST MARKET SHARE, BY COUNTRY, 2016 (%) 107

FIGURE 20 THE MIDDLE EAST AND AFRICA: CREATININE TEST MARKET SHARE, BY REGION, 2016 (%) 130

FIGURE 21 GLOBAL CREATININE TEST MARKET, MARKET SHARE ANALYSIS 2016 (%) 141

FIGURE 22 GLOBAL CREATININE TEST MARKET: COMPETITIVE LANDSCAPE 2016 (%) 142



Global Creatinine Test Market: Competitive Landscape


Siemens AG, Abbott Diagnostics Inc., Thermo Fisher Scientific, F. Hoffmann-La Roche AG, and The Danaher Corporation collectively accounted for more than 70.5% market share of the global creatinine test market in 2016. These companies continue to retain their strong global presence through acquisitions and product launches.


In 2016, Siemens accounted for the largest market share of the global creatinine test market, with more than 21.2% of the market share. The large share of the company is attributed to the high demand for creatinine testing globally. Moreover, this company offers various new products in the creatinine test market. For instance, in 2018, Siemens Healthineers received an FDA approval for its Blood Urea Nitrogen (BUN) and Total Carbon Dioxide (TCO2) point-of-care tests to aid in the diagnosis of renal diseases and metabolic imbalances.


Abbott held the second position in terms of market share, in 2016. The company focuses on delivering integrated solutions to large healthcare customers. Also, the company is focusing on acquisitions for establishing a strong position in the market. For instance, in Oct 2017, Abbott completed the acquisition of Alere Inc. for USD 5.3 Billion. The acquisition will establish a strong position of Abbott in the diagnostics market.


Thermo Fisher Scientific Inc. acquired the third spot in the market. The company follows a strategy of introducing a strong product portfolio at lower costs which help them to retain the position in the market.



  1. Hoffmann-La Roche AG holds the fourth place in the market owing to the strategy of identifying & developing promising technologies and potential products and focusing on merging and acquisitions with other groups to develop and identify new products and technologies. For instance, in Nov 2017, Roche announced to acquire Viewics, Inc. to expand its leading position in the Integrated Core Lab with business analytics capabilities.


The Danaher Corporation is a global technology and science innovator focusing on helping their customers solve complex challenges and improve quality of life around the world. It holds the fifth position in the global creatinine test market owing to new launches and global presence in the market. In 2017, the company announced the launch of its CE-marked point-of-care tests for creatinine and urea, the latest additions to the ABL90 FLEX PLUS blood gas analyzer’s test menu.


There are many other players present in the market such as ARKRAY, Inc., Quest Diagnostics Inc., URIT Medical, OPTI Medical Systems, Inc., ACON Laboratories, Inc., Nova Biomedical, Abcam plc, and others which accounts cumulatively for nearly 29.5% of the global market share. The companies are adopting the strategy of product launches and acquisitions to solidify their position in the market. New product developments are a key focus area for players.